161 related articles for article (PubMed ID: 34347376)
21. MALDI-TOF-MS analysis in low molecular weight serum peptidome biomarkers for NSCLC.
Song Y; Xu X; Wang N; Zhang T; Hu C
J Clin Lab Anal; 2022 Apr; 36(4):e24254. PubMed ID: 35212031
[TBL] [Abstract][Full Text] [Related]
22. Urinary malate dehydrogenase 2 is a new biomarker for early detection of non-small-cell lung cancer.
Ma YC; Tian PF; Chen ZP; Yue DS; Liu CC; Li CG; Chen C; Zhang H; Liu HL; Zhang ZF; Chen L; Zhang B; Wang CL
Cancer Sci; 2021 Jun; 112(6):2349-2360. PubMed ID: 33565687
[TBL] [Abstract][Full Text] [Related]
23. Exosomal lipids for classifying early and late stage non-small cell lung cancer.
Fan TWM; Zhang X; Wang C; Yang Y; Kang WY; Arnold S; Higashi RM; Liu J; Lane AN
Anal Chim Acta; 2018 Dec; 1037():256-264. PubMed ID: 30292300
[TBL] [Abstract][Full Text] [Related]
24. Urinary metabolomics for discovering metabolic biomarkers of bladder cancer by UPLC-MS.
Wang R; Kang H; Zhang X; Nie Q; Wang H; Wang C; Zhou S
BMC Cancer; 2022 Feb; 22(1):214. PubMed ID: 35220945
[TBL] [Abstract][Full Text] [Related]
25. Plasma characteristic metabolites of pediatric community-acquired pneumonia in traditional Chinese medicine syndrome differentiation.
An L; Lin L; Wang S; Xie T; Yang Y; Zhai W; Du L; Li W; Shen C; Zhang Y; Shan J
Anat Rec (Hoboken); 2021 Nov; 304(11):2579-2591. PubMed ID: 34549900
[TBL] [Abstract][Full Text] [Related]
26. Triple Negative Breast Cancer Detection Using LC-MS/MS Lipidomic Profiling.
Eghlimi R; Shi X; Hrovat J; Xi B; Gu H
J Proteome Res; 2020 Jun; 19(6):2367-2378. PubMed ID: 32397718
[TBL] [Abstract][Full Text] [Related]
27. Combined metabolomics with transcriptomics reveals potential plasma biomarkers correlated with non-small-cell lung cancer proliferation through the Akt pathway.
Zheng J; Zheng Y; Li W; Zhi J; Huang X; Zhu W; Liu Z; Gong L
Clin Chim Acta; 2022 May; 530():66-73. PubMed ID: 35245482
[TBL] [Abstract][Full Text] [Related]
28. UPLC-MS/MS-based plasma lipidomics reveal a distinctive signature in systemic lupus erythematosus patients.
Chen J; Liu C; Ye S; Lu R; Zhu H; Xu J
MedComm (2020); 2021 Jun; 2(2):269-278. PubMed ID: 34766146
[TBL] [Abstract][Full Text] [Related]
29. UPLC-QTOF-MS-Based Plasma Lipidomic Profiling Reveals Biomarkers for Inflammatory Bowel Disease Diagnosis.
Guan S; Jia B; Chao K; Zhu X; Tang J; Li M; Wu L; Xing L; Liu K; Zhang L; Wang X; Gao X; Huang M
J Proteome Res; 2020 Feb; 19(2):600-609. PubMed ID: 31821004
[TBL] [Abstract][Full Text] [Related]
30. Tumor-derived exosomal proteins as diagnostic biomarkers in non-small cell lung cancer.
Niu L; Song X; Wang N; Xue L; Song X; Xie L
Cancer Sci; 2019 Jan; 110(1):433-442. PubMed ID: 30407700
[TBL] [Abstract][Full Text] [Related]
31. Detection of circulating genetically abnormal cells in peripheral blood for early diagnosis of non-small cell lung cancer.
Liu WR; Zhang B; Chen C; Li Y; Ye X; Tang DJ; Zhang JC; Ma J; Zhou YL; Fan XJ; Yue DS; Li CG; Zhang H; Ma YC; Huo YS; Zhang ZF; He SY; Wang CL
Thorac Cancer; 2020 Nov; 11(11):3234-3242. PubMed ID: 32989915
[TBL] [Abstract][Full Text] [Related]
32. Integration of metabolomics and machine learning revealed tryptophan metabolites are sensitive biomarkers of pemetrexed efficacy in non-small cell lung cancer.
Sun R; Fei F; Wang M; Jiang J; Yang G; Yang N; Jin D; Xu Z; Cao B; Li J
Cancer Med; 2023 Sep; 12(18):19245-19259. PubMed ID: 37605514
[TBL] [Abstract][Full Text] [Related]
33. Metabolic signatures of hepatolithiasis using ultra-high performance liquid chromatography-tandem mass spectrometry.
Wang C; Yang J; Li E; Luo S; Sun C; Liao Y; Li M; Ge J; Lei J; Zhou F; Wu L; Liao W
Metabolomics; 2022 Aug; 18(9):69. PubMed ID: 35976530
[TBL] [Abstract][Full Text] [Related]
34. Lipid metabolism and identification of biomarkers in asthma by lipidomic analysis.
Jiang T; Dai L; Li P; Zhao J; Wang X; An L; Liu M; Wu S; Wang Y; Peng Y; Sun D; Zheng C; Wang T; Wen X; Cheng Z
Biochim Biophys Acta Mol Cell Biol Lipids; 2021 Feb; 1866(2):158853. PubMed ID: 33160078
[TBL] [Abstract][Full Text] [Related]
35. Plasma lipid profile comparison of five different cancers by nanoflow ultrahigh performance liquid chromatography-tandem mass spectrometry.
Lee GB; Lee JC; Moon MH
Anal Chim Acta; 2019 Jul; 1063():117-126. PubMed ID: 30967175
[TBL] [Abstract][Full Text] [Related]
36. Study on plasma amino acids and piperonamide as potential diagnostic biomarkers of non-small cell lung cancer.
Zhang C; Wang Y; Cao Y; Shi L; Wang R; Sheng N; Wang Q; Zhu Z
Transl Cancer Res; 2022 May; 11(5):1269-1284. PubMed ID: 35706818
[TBL] [Abstract][Full Text] [Related]
37. Non-Small Cell Lung Cancer Detection and Subtyping by UPLC-HRMS-Based Tissue Metabolomics.
Zang X; Zhang J; Jiao P; Xue X; Lv Z
J Proteome Res; 2022 Aug; 21(8):2011-2022. PubMed ID: 35856400
[TBL] [Abstract][Full Text] [Related]
38. Lipid profiling in malignant mesothelioma reveals promising signatures for diagnosis and prognosis: A plasma-based LC-MS lipidomics study.
Chen Z; Song S; Yang C; Dai Z; Gao Y; Li N; Zhu J; Mao W; Liu J
Clin Chim Acta; 2022 Jan; 524():34-42. PubMed ID: 34843704
[TBL] [Abstract][Full Text] [Related]
39. Salivary Lipids of Patients with Non-Small Cell Lung Cancer Show Perturbation with Respect to Plasma.
Hwang BY; Seo JW; Muftuoglu C; Mert U; Guldaval F; Asadi M; Karakus HS; Goksel T; Veral A; Caner A; Moon MH
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762567
[TBL] [Abstract][Full Text] [Related]
40. Plasma lipidomics reveals potential lipid markers of major depressive disorder.
Liu X; Li J; Zheng P; Zhao X; Zhou C; Hu C; Hou X; Wang H; Xie P; Xu G
Anal Bioanal Chem; 2016 Sep; 408(23):6497-507. PubMed ID: 27457104
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
